This virtual conference will bring together leading experts in RNA editing and modifications, technology development, and medicine to present and discuss cutting edge research. We anticipate that participants of this conference will benefit from learning the cutting edge of the rapidly advancing field and help move the field forward by creating collaboration opportunities.

Fueled by the rapid advancements in both epigenetic research as well as translational gene editing and gene therapy, the EpiBio conferences were established in 2017 as a platform for synthetic biologists developing tools for epigenetic reprogramming.

The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.

Burgeoning knowledge about the RNA world is opening up new opportunities to understand disease and develop therapeutic and diagnostic interventions. As RNA therapeutics continue to change the face of clinical practice, this conference explores progress in our understanding of the numerous roles of RNAs in cellular functions and diseases and efforts to translate advances in basic science into safer and more efficacious therapies, with a particular emphasis this year on clinical advances in cardiovascular and metabolic disease.

AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. We foster research that leads to improved treatment options for millions of liver disease patients. We advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.

CRISPR 2.0 is the industry-leading meeting dedicated to answering this question by showcasing only the latest and greatest innovations in CRISPR technology, from the potential of prime editing through to epigenome editing to treat chronic pain.

Attend the world’s most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology.

This conference will encompass themes of chromatin mechanisms, including DNA and RNA modifications, histone modifications, ATP-dependent nucleosome remodeling complexes, histone variants, chaperones and others, as they intersect with cell identity, cellular and transgenerational memory, with genome function, with nuclear structure, and with biological questions and disease implications.

MEETING CANCELED The mechanisms underlying nucleosome- and chromatin-based functional control [...]

Rare Disease Day® (link is external) takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. Each year, NCATS and the NIH Clinical Center sponsor Rare Disease Day at NIH as part of this global observance. Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations underway to address scientific challenges and to advance new treatments.

Over the last several years, new genome engineering tools have revolutionized the ability to interrogate biological systems, engineer innovative biotechnologies, and model and treat human disease. The genome engineering field continues to evolve at a frenzied pace, including both the development of new fundamental tools and their application to addressing societal needs. This Keystone Symposium will cover this spectrum of advances, including the most recent technological innovations in genome, epigenome, and transcriptome precision engineering.

The American Society of Human Genetics envisions a future where people everywhere realize the benefits of human genetics and genomics research. We work to advance human genetics and genomics in science, health, and society through excellence in research, education, and advocacy.

The 2021 ACMG Annual Clinical Genetics Meeting will present both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions will focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

Presented by the Society for Biological Engineering (SBE), the CRISPR Tech 2020 conference will bring together academics and industry representatives to highlight the cutting edge of these developments and the most immediate technical and societal changes.

A large number of long non-coding RNAs (lncRNAs) with a surprisingly wide-range of cell-type specific expression profiles are present in human transcriptomes. Emerging evidence points to their critical roles in human physiology and pathology and some are recognized as potential therapeutic targets. However, many seminal questions in regard to their mechanism of action remain largely unexplored.

ASGCT 24th Annual Meeting Join Jennifer Doudna, Ph.D., for a Fireside Chat

Usher 1F Collaborative is pleased to announce our scientific research conference, Therapeutic Strategies for Large Protein Coding Genes in Usher Syndrome.

International Conference on Genome Evolution aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Genome Evolution. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Genome Evolution.

Adenoviruses are associated with gastroenteritis, conjunctivitis, respiratory and urinary tract infections which in general have low clinical relevance. However, they can cause severe pathologies, even life-threatening, in immunosuppressed individuals. There is no efficient treatment for adenovirus infections approved so far.

The 26th Annual Meeting of the RNA Society will be a Virtual Meeting, from May 25 to June 5, 2021.

Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2021) will be held from May 29-31, 2021 in Guilin, China. GECT 2021 will cover issues on Biomedicine, Clinical Application of Gene Editing,CRISPR Systems and CRISPR Technologies,Effective Delivery for Genes in Vitro,Gene Knock In and Genomic Screening,Genome Engineering and DNA repair,Single Base Editing, etc. It dedicates to creating a stage for exchanging the latest research results and sharing the advanced research methods.

The description for this conference is being developed by the conference chairs. Please check back regularly for updates to this information.

The Paris CRISPR 2020 meeting has been cancelled. The CRISPR 2021 meeting will be organized virtually from June 1 to 10, 2021. Mark your calendar!

Currently, technological developments are offering the hope of new therapies for individuals with rare disease at a pace that has the potential for significantly challenging the existing infrastructure for efficient, effective, and equitable delivery.

This conference aims to provide an integrated discussion of the latest advances in research and therapeutic development for neurodegenerative diseases.

Remarkable developments in genome editing are revolutionizing medicine and agriculture as large animal genomes can, for the first time, be modified with sophistication and efficiency so far only achievable in the mouse. This technology allows for improvement in livestock production traits, agricultural animal health and welfare, and generation of more refined large animal models for biomedical applications. The summit will bring together reproductive biologists, geneticists, molecular biologists, animal model developers, preclinical and clinical researchers, and representatives of federal research and regulatory agencies.

Biotherapeutics, including protein and nucleic acid-based therapeutics, cell and gene [...]

This is the only international conference that focuses on Vitamin A. In a spirit of cross-disciplinary education, this meeting provides a "home base" for diverse scientists to review the latest concepts and information about retinoid biology and to assess new developments.

Currently, technological developments are offering the hope of new therapies for individuals with rare disease at a pace that has the potential for significantly challenging the existing infrastructure for efficient, effective, and equitable delivery.

Coming Soon.

Coming soon

Currently, technological developments are offering the hope of new therapies for individuals with rare disease at a pace that has the potential for significantly challenging the existing infrastructure for efficient, effective, and equitable delivery.

The Gordon Research Seminar on Drug Metabolism is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

The 50th Gordon Research Conference on Drug Metabolism will approach ADME (absorption, distribution, metabolism, elimination) science from a perspective that focuses on patients as unique individuals, in contrast to the more traditional "population" perspective, as a preparatory step to delivering precision therapeutics.

Due to the uncertainty of COVID we are planning for an entirely virtual meeting with the potential for a blended event. If possible, Thursday and Friday events will also be held both in-person at the Graduate Hotel [Minneapolis] and online.

The seminar chair is currently developing an outline of the [...]

The chair is currently developing a description for this conference. This information will be available by September 30, 2020. Please check back for updates.

As is the tradition for this conference, we will strive to provide a gender balanced and an ethnically and geographically diverse meeting that allows investigators to present novel findings and new approaches while also providing a collegial opportunity for all participants to interact.

The chair is currently developing a description for this conference. This information will be available by October 7, 2020. Please check back for updates.

Nanoporous materials have a broad range of capabilities, which have enabled their use in many industrially relevant processes. The utility of each material is driven by understanding and controlling the order and disorder in the system through theoretical understanding, targeted synthesis, and material engineering. This meeting focuses on building relationships between young scientists engaged in the design, synthesis, characterization, and application of porous materials by providing an informal, collaborative environment renowned for facilitating open discussion of unpublished, cutting-edge research.

The field of epigenetics ranges from the phenomenological to detailed understanding of molecular mechanisms. This meeting focuses on diverse systems, approaches, and experimental innovations to discern the core principles of non-genetic mechanisms of inheritance. Topics will include the nature of epigenetic memory in the germ line and soma, across cell division, during development, in response to the environment, and in disease states. Diverse forms of epigenetic information will be considered.

The description for this conference is being developed by the conference chairs. Please check back regularly for updates to this informatio

The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR and related bacterial defense systems.

Coming soon

During this two day conference, the latest developments in the fields of Genome Engineering and Synthetic Biology will be presented by over 30 speakers from academia and industry. The world-renowned academics will showcase their latest research breakthroughs, while the technology developers in industry present their disruptive new technology platforms which drive the field forward.

This interactive virtual course will provide training in genome editing [...]

Coming soon

This annual meeting brings together scientists, clinicians, and caregivers from around the world to discuss and share ideas on the latest advances in CF research, care, and drug development and to exchange ideas about ways to improve the health and quality of life for people with CF.

Plan to join us October 18-22, 2021 for another great [...]

ESGCT organises an Annual Congress, which brings together scientists working in the fields of gene and cell therapy from throughout Europe and beyond. The congress is typically held in October or November in a major European city

The field of genome engineering is progressing at warp speed, transforming the way scientists execute large-s

International Conference on Gene Expression Engineering and Expression Systems aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Gene Expression Engineering and Expression Systems.

International Conference on Organs-on-a-Chip Devices aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Organs-on-a-Chip Devices. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Organs-on-a-Chip Devices

This annual meeting brings together scientists, clinicians, and caregivers from around the world to discuss and share ideas on the latest advances in CF research, care, and drug development and to exchange ideas about ways to improve the health and quality of life for people with CF.

EpiBio explores the basics and cutting-edge technologies and applications related to the epigenome. The conference brings together interdisciplinary expertise in the field — allying biology, chemistry, physics, data processing (bioinformatics), and engineering to foster the development of novel methodologies and tools to answer biological questions in epigenetics. You’ll gain an understanding of current advances and future prospects in epigenetic engineering.

Coming soon

The Gliwice Scientific Meeting is an annual event of international scope organized jointly by the Center of Oncology in Gliwice, Poland, together with the Silesian University of Technology. The Meetings are held under the auspices of the Association for the Support of Cancer Research, a local non-profit organization seeking progress in anticancer research. The conference topics usually cover recent advances in molecular biology, biotechnology, genetics and bioinformatics that have an impact on cancer research, ranging from basic studies to clinical applications.

Helping hematologists conquer blood diseases worldwide

Join us at the Georgia World Congress Center in Atlanta, Georgia – or virtually – from December 11-14, 2021, to discover the newest advances in hematology. You won’t want to miss the world’s premier event in malignant and non-malignant hematology!

International Conference on Tissue Engineering in Biomedicine aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Tissue Engineering in Biomedicine.

Transcriptional control is at the heart of developmental and disease processes. Over decades, the field gene regulation continues to elucidate how interactions between regulatory factors and elements in genomic DNA and nascent RNA control gene expression. This year, we celebrate the 40th anniversary of the enhancer, genomic DNA distal to gene promoters that controls transcription.

Precision genome engineering has completely revolutionized biological research and is making groundbreaking inroads to therapies. Progress is rapid and the ability for researchers to meet and network is essential in order to stay updated with the latest advances in the field.

The conference is intended to foster cross-disciplinary exchange of ideas and expertise between experimentalists and computational biologists interested in the organization and control of complex transcription networks in eukaryotes.

Organoids are complex three-dimensional in vitro organ-like model systems. Organoids can be derived from pluripotent stem cells or primary donor tissue and have been used to address fundamental questions about development, stem cell biology and organ regeneration. Human organoids have highlighted significant unknowns in human biology and have invigorated new exploration into the cellular makeup of human organs during development, in the adult and during disease.

RNA-based therapeutics are already approved for a variety of human diseases. A large and diverse set of small regulatory RNAs have emerged as key regulators of gene expression during development and cellular homeostasis and are frequently mis-expressed in human disease.

International Conference on CRISPR Technology and Applications aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of CRISPR Technology and Applications. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of CRISPR Technology and Applications

International Conference on Genetic Engineering and Genome Research aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Genetic Engineering and Genome Research. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Genetic Engineering and Genome Research

International Conference on DNA, Genome Engineering and Technology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of DNA, Genome Engineering and Technology. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of DNA, Genome Engineering and Technology

International Conference on DNA, Genome Engineering and Technology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of DNA, Genome Engineering and Technology. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of DNA, Genome Engineering and Technology

The Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. ASGCT's annual meeting brings together more than 3,400 professionals including scientists, physicians, and patient advocates.

Topics include, Micro RNAs, DNA Modification and Novel RNA Biology, Long Non-coding and Circular RNAs, RNA Regulation in the Nucleus, piRNAs and the Transmissible RNAs, Microbial RNAs and Modifications.

International Conference on DNA Structure and Genome Engineering aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of DNA Structure and Genome Engineering. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of DNA Structure and Genome Engineering

The aim of GECT is to provide a stage for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research results and development activities in Biomedicine, Clinical Application of Gene Editing, CRISPR Systems and CRISPR Technologies, Effective Delivery for Genes in Vitro, Gene Knock In and Genomic Screening, Genome Engineering and DNA repair, Single Base Editing, etc.

International Conference on Genome Engineering aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Genome Engineering. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Genome Engineering

Launched in 2010—as the explosion of interest in technologies that can precisely manipulate the genomes of living cells began—this FASEB Science Research Conference (SRC) provides a timely update on this rapidly developing field. The program spans from the latest technology developments to reports of applications in human disease and agriculture. This conference brings together equal numbers of scientists from academia and industry who represent scientific research from multiple countries.

At this conference, renowned experts will address challenges and discoveries in the cell therapy and immunotherapy arenas that will ultimately change the future of healthcare. Meet thought leaders from clinical, industrial, and academic settings, who will discuss the latest developments in these fields.

Join us in Minneapolis, Minnesota, on July 27, 28, and 29 for the 2022 Genome Writers Guild (GWG) annual conference. We are planning a hybrid event — in-person (pandemic permitting) and virtual-streaming of the program. We’re inviting a diverse representation of speakers from industry, academia, students, postdocs, professors, and more.

It is possible to find answers and hope. It is possible to find a community of people who understand what you’re going through. It is possible to find answers from world renowned experts. It is possible to live your best life with sarcoidosis. Newly diagnosed and long-term sarcoidosis patients, caregivers, and family and friends of someone impacted by sarcoidosis are all invited to attend this year’s Summit. Unveiling Possibilities will bring connection, expertise, and shared experiences to help you and your loved ones throughout your sarcoidosis journey.

The Midwest Symposium on Oligonucleotide Therapeutics is a grassroots meeting in Indianapolis supported by an Oligonucleotide Therapeutics Society (OTS) Local Delivery Grant. This regional meeting is hosted by OTS members, Rebecca Miles and Leonora Abdullahu with the objective to share knowledge among oligonucleotide therapeutic researchers. We hope to serve the student community in the Midwest to create an affordable and high value scientific meeting that will cultivate professional development and networking.

The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR-Cas and related bacterial defense systems.

All are welcome to register and join the 2022 DOE Joint Genome Institute (JGI) Genomics of Energy & Environment Meeting, which coincides with our 25th Anniversary. The JGI convenes this annual gathering of leaders from diverse disciplines to highlight how they are addressing the world’s most pressing energy and environmental challenges. Many of these presenters have been supported by the research infrastructure – DNA sequencing, synthesis, metabolomics, data analysis, and new technology developments – that the JGI offers through its User Programs on a competitive, peer-reviewed basis to the worldwide scientific community. This year’s Meeting, to be held August 29 – 31, will be a hybrid event ­– in person at Lawrence Berkeley National Laboratory (Berkeley Lab) – and virtually through the Social27 platform.

This year we are bringing the event back to be more commercially and strategically focused, where in an intimate setting attendees will have the opportunity to connect with the full cell & gene community, enabling a 360-degree view on the current landscape.   It’s the destination for those wanting to debate the challenges, explore the opportunities, and discover the latest innovations, all within Europe and the UK.  In a bespoke setting, attendees will have access to the complete European advanced therapies landscape from macro to micro.  It’s the only event to offer companies a credible platform to position their company and solutions as leading providers in the advanced therapies technology and services space, including being able to place their brand directly under the nose of key decision makers from across Europe and the UK. Hosted in London the event is positioned front and center of all the action within the European advanced therapies landscape.

Each year, Global Genes convenes one of the world’s largest gatherings of rare disease patients, caregivers, advocates, healthcare professionals, researchers, partners, and allies at the RARE Patient Advocacy Summit. This year we’re celebrating being back together again, and have opportunities for you to join us in person or online for two days of connection opportunities, educational sessions, fun, and the RARE Champions of Hope Awards Ceremony and Dinner! Summit sessions provide attendees with insights about the latest in rare disease innovations, best practices for advocating on an individual and organizational level, and actionable strategies to take home. This year, the Summit will be a hybrid event so all can attend – in person at the Town & Country Hotel in San Diego, California and live streamed online in our virtual event platform.

With over 20 CGTs projected to be approved by 2025, it’s clear that there are huge commercial and medical opportunities for precision medicine. But despite this unprecedented growth, unstable infrastructure, lack of standardization and novel scientific nuance means that there is still no industry blueprint for successful commercialization. To realize this potential, precision medicine trailblazers must share lessons of launch success and overcome pain points to allow pharma to reinforce frameworks across manufacturing, market access and reimbursement to build infallible launch strategies across the board. Commercialization networks must go even further, transforming our healthcare system to guarantee scalable and sustainable growth. Don’t get left behind. Join us at Reuters Events: Cell and Gene Therapy USA where we have leaders from industry front runners to share their successes and pitfalls. With 30+ speakers, 5 case-studies and over 1500+ fellow CGT attendees - we will pioneer a new gold standard for commercialization, readying the world for CGT as a frontline treatment.

The International Society for Stem Cell Research (ISSCR) and the American Society for Gene and Cell Therapy (ASGCT) are partnering to host an exciting program on the latest advancements in regenerative medicine at the intersection of genetic and cellular technologies. The marriage of genomic and cellular advances holds tremendous potential for regenerative medicine. Recent discoveries in stem cell biology are being combined with powerful new gene-editing technologies to bring about potentially transformative new therapies for diseases affecting a wide range of tissue and organ systems. This three day meeting will highlight groundbreaking work developing therapies for diseases of the nervous, hematopoietic, and muscle systems, diabetes, metabolic diseases, and cancer, and feature forward-looking new technologies shaping the future of the field. Join us on 21 - 23 September 2022 when world-renowned scientists developing gene and cell therapies will converge at the Monona Terrace Community and Convention Center in Madison, WI, a city recognized for its seminal contributions to human stem cell research. Scientists, researchers, and industry leaders will present new discoveries at the leading edge of regenerative medicine.

This is a fascinating, exciting, and perplexing time for biotechnology. The industry delivered RNA vaccines to save countless lives during the pandemic and has created impressive early clinical results using CRISPR gene editing to treat patients with deadly genetic diseases. And yet the sector has been tarnished with safety concerns, drug failures, and lay-offs. For more than 40 years, Genetic Engineering & Biotechnology News (GEN) has been covering the world of biotechnology. This September, we will cover it as never before – in a must-attend virtual event hosted by GEN Edge, the premium subscription news service of GEN. THE STATE OF BIOTECH is an essential virtual summit (spanning two half days) featuring leaders from industry, academia, and finance discussing the latest critical breakthroughs, trends, and challenges in the biotech industry. The event will feature presentations and conversations with a trove of biotech leaders and entrepreneurs, brilliant scientists and innovators, and renowned analysts and commentators.

Gene Forum takes the honour to invite you to the International Human Gene Conference which will be held on September 26-28, 2022 at Melbourne Australia. Over the past few years, Gene therapy has become a regular talk for the scientists and researchers from academia and industry all over the globe. Gene therapy is very huge and more team’s diverse research is needed to find the effective treatments and best possible ways to manage the rare diseases. With a great substantial research on genetics happening in this part of the world, therefore it has developed into a forum to discuss important challenges in this field. The aim of the conference is to bring together all the key stakeholders interested in genetics and gene therapy to share and discuss advances and developments in these fields. Therefore we aimed at assisting academicians, business executives, researchers, scientists, manufacturers, gene therapy companies, communities, and agencies to keep on new developments in their specific fields and to join forces in finding alternative solutions. It’s a unique way to approach and encourage a dialogue between speakers and delegates through its well-planned agenda with the series of talks, poster presentations, panel discussions and networking events that will keep participants engaged in learning. This will help rising scientific queries and provide solutions for a smarter and more advanced future. We are stepping forward to create a platform to bring all the researchers from around the world and the research community to collaborate with the industries to focus on their efforts. The industry partners and attending experts will also provide a fantastic networking experience.

The World Molecular Imaging Congress brings together people from across the globe who represent the entire spectrum of Molecular Imaging. These individuals gather at WMIC to exchange ideas and foster innovation. The scientific and educational sessions are replete with leaders in the field and young scientists alike, each of whom has made significant contributions to our understanding of biology, advanced technology innovation, and/or evaluated new developments in the clinic. These sessions are complemented by thousands of abstracts that detail advances and highlight the latest developments in Molecular Imaging. Our industry exhibitors and sponsors showcase their innovations in the exhibition hall and lecture hall, detailing advances that will refine your animal models, accelerate your research, and improve clinical care. Each WMIC session is packed with innovative ideas and cutting-edge research. Molecular Imaging is a window into biology that enables discovery. We use these windows to investigate new biology and increase understanding, and the better we understand biological processes of living systems, with all of the contextual influences intact, the more effective our therapies will be in the clinic. Molecular Imaging lies at the heart of precision medicine. WMIC is the event that showcases all of the innovations in Molecular Imaging and shows the utility of novel imaging strategies in clinical investigation and the study of disease. Molecular Imaging as a field lies at the nexus of innovation in chemistry, hardware development, software innovation, biology, and medicine, and the WMIC is where you will hear about the most exciting highlights and the most in-depth evaluation. You will not want to miss WMIC 2022 in Miami!

The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society's mission and goals, to foster academic and industry-based research and development of oligonucleotide therapeutics. Leaders in the field from across the globe alongside students will present on an array of topics, including chemistry, AI/machine learning, genome & RNA editing, and preclinical and clinical research. The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics.

The VEGA 2022 symposium aims to bring together a “viral ecogenomics” community to foster discussion on how to best capture and characterize uncultivated viruses, understand the role of viruses in natural ecosystems, and functionally explore viral genetic diversity toward innovative biotechnological and industrial applications. This 2022 edition will focus in particular on experimental innovations, computational advances, and other technological developments that will enable researchers to functionally characterize novel viral diversity and investigate virus-virus and virus-host interactions in nature. The symposium will also include organized discussion sessions to gather input from the community on the most pressing challenges faced by researchers in the viral ecogenomics fields. Participants will notably be invited to open discussions designed to shape the future design of IMG/VR (the database of uncultivated viral genomes) to maximize its usefulness for the different actors in the field (i.e. gene-centric experimental approaches, ecosystem models, host-based evolutionary analysis, etc), as well as frame a potential viral-focused calls for projects at the JGI.

Our annual conference highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments. The drug repurposing field has shifted after stepping into the limelight during the COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognizing the opportunities to repurpose a drug to treat an often rare and neglected condition. Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines – the answers have been right under our noses all along!

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Cardiovascular disease model research has seen remarkable advances in the last decade. The technology is staggering, the magnitude of human studies is extraordinary, the sophistication of animal models is outstanding, and the revelations regarding the insights into the genomics and other omics are absolutely fascinating. Yet the future prospects are even more exciting. These will be core elements of the Cardiovascular Disease Model Satellite 2022, with the main theme: “Innovative science of hypertension-related disease model towards precision medicine and prevention” to envision the future, building on today’s achievements. Cardiovascular Disease Model Satellite 2022 is an official investigator-led satellite to the International Society of Hypertension Meeting in October 2022 and we are delighted that it will also incorporate the 20th International SHR Symposium and the 58th Japanese SHR Meeting. We should like you to be part of this stimulating meeting. The quality of our Committees and International Advisory Board will ensure that the research presented is at the forefront of the field. This will include the latest in genomics and other omics discovery, control and integration of gene expression, biomarkers, systems biology, pharmacogenomics, epigenetics and functional validation. The Satellite will span 1.5 days and will be held on Sunday 16 and Monday 17 October 2022. Although the Satellite was scheduled to be held in a hybrid format (face-to-face and virtual), I announce with great regret that we have decided to hold the meeting in a semi-hybrid format. That is, except for the speakers who can come to deliver their presentation at the venue located within the Kyoto University, the other speakers and the audience will participate in the meeting online. As an Investigator-Led Satellite, we are keeping costs to minimum and you will find details regarding Abstract Submission, Registration and related matters on this website. We look forward to your participation in a memorable meeting and contribution to future of Cardiovascular Disease Model Research.

The NYSCF Conference is the premier translational stem cell research conference. Held annually for the past 16 years, it has brought together world-leading experts from various disciplines across biomedicine and biotechnology to present the latest cutting-edge stem cell science.